Undergraduate researcher given top honors from College of Arts and Sciences.

Published in Student Experience

Research suggests that a class of drugs for rheumatoid arthritis seeking approval this year could be effective against other autoimmune diseases.

Two UAB departments unite to become integrated research team.
Quirky evolution yields clues to a fatal condition.
Published in Focus on Patient Care
Kathleen Berecek, Ph.D., has been named professor emerita of physiology and biophysics in the UAB School of Medicine and School of Dentistry.
Published in Faculty Excellence

New research from UAB shows definitive link between a protein and cell activation; shutting both down could be a target of new treatments for cancer and autoimmune diseases.

Tigatuzumab, developed at UAB with Daiichi-Sankyo, targets aggressive, hard-to-treat tumors that make up 25 percent of all breast cancers

Published in Focus on Patient Care
Back to Top